Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belimumab concentrations in blood, saliva, and seminal fluid in adults with systemic lupus erythematosus
NL-OMON49577Active, not recruiting
- Sponsor
- Vrije University Medical Center
- Start
- Jul 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label trial of belimumab in systemic lupus erythematosus (SLE) (2 arms), sponsored by Vrije University Medical Center. Primary endpoint: Belimumab concentration in seminal fluid. Started Jul 2020; status: active, not recruiting.
02
Drugs
belimumab
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NL-OMON49577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49577.